News

Alphabet’s Isomorphic Labs has grand ambitions to ‘solve all diseases’ with AI. Now, it’s gearing up for its first human trials
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to address that disease,” Colin Murdoch, Isomorphic Labs president and Google DeepMind's chief business officer said.
Google-backed Isomorphic Labs to launch human trials for AI-designed drugs
Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.
Isomorphic Labs prepares to launch trials for AI-designed drugs
In an interview with Fortune, Isomorphic Labs president Colin Murdoch shared that four years after its founding, the company is preparing to dose the first patients in clinical tr
Google’s Isomorphic Labs “Very Close” To Starting Human Trials For AI-Generated Medicines
Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And his company is on track to put these words into practice. Isomorphic Labs,
Google DeepMind is ready to start human trials of AI-designed drugs; company exec says, ‘We’re getting very close’
Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in pharmaceutical innovation.
Google DeepMind to soon begin human trials of AI-designed drugs
Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a significant leap in pharmaceutical innovation.
AI-Designed Drugs? Isomorphic Labs Prepares for First Human Trials
Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical research.
Google Ready To Start Human Trials Of Its AI-Designed Drugs
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
Google’s AI-designed cancer drug may soon enter human trials, says DeepMind exec
Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in fields like cancer and immunology using artificial intelligence.
Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is…'
Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...
NBC New York3mon
Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind - NBC New York
Isomorphic Labs is the secretive AI life sciences startup spun out of Google DeepMind with the goal of solving all disease with AI-powered drug discovery. Skip to content. Main Navigation.
STAT21d
Isomorphic Labs builds U.S. presence, with an eye on clinical trials - STAT
Isomorphic Labs is setting up an office in Cambridge, Mass., as it prepares for clinical trials of some of its AI-enabled drug candidates.
The Boston Globe21d
Isomorphic Labs sets up Cambridge outpost, with an eye on clinical trials - The Boston Globe
As Isomorphic Labs aims its artificial intelligence tools at drug development, it’s setting up a new outpost in the biotech hub of Cambridge.